Table 3 Preoperative characteristics in patients undergoing LVAD implantation at UAB, 2017-2020
From: Preoperative hemodynamics as predictors of right heart failure post-left ventricular assist device
Pre-operative Characteristics | Overall (n=114) | RHF (n=70) | No RHF (n=44) | p-value |
|---|---|---|---|---|
Pre-op SysPAP (mmHg) | 49.7 ± 12.7 | 51.3 ± 12.3 | 47.2 ± 13.0 | 0.0931 |
Pre-op DiaPAP (mmHg) | 25.9 ± 7.9 | 26.8 ± 6.8 | 24.5 ± 9.3 | 0.1239 |
Pre-op CVP (mmHg) | 9.9 ± 5.5 | 10.4 ± 5.6 | 9.1 ± 5.4 | 0.2191 |
Pre-op PAPi (mmHg) | 3.4 ± 2.7 | 3.1 ± 2.1 | 3.8 ± 3.4 | 0.2100 |
Pre-op PWP (mmHg) | 27.3 ± 9.9 | 28.5 ± 9.6 | 25.5 ± 10.1 | 0.1195 |
Pre-op CVP/PWP | 0.4 ± 0.5 | 0.4 ± 0.2 | 0.5 ± 0.8 | 0.2774 |
History of Hypertension | 74 (68.5%) | 45 (68.2%) | 29 (69.0%) | 0.9248 |
Hyperlipidemia | 76 (70.4%) | 44 (66.7%) | 32 (76.2%) | 0.2907 |
History of diabetes | 52 (48.6%) | 29 (43.9%) | 23 (56.1%) | 0.2212 |
Current Smoker | 10 (9.3%) | 5 (7.7%) | 5 (11.9%) | 0.4648 |
Chronic Lung Disease | 26 (24.1%) | 13 (19.7%) | 13 (31.0%) | 0.1823 |
Pre-op Medication: ACEI or ARB | 14 (13.3%) | 8 (12.7%) | 6 (14.3%) | 0.8147 |
Pre-op Creatinine mg/dL | 1.2 ± 0.3 | 1.2 ± 0.3 | 1.1 ± 0.3 | 0.2500 |